Prospect: information for the patient
Gabapentina Sandoz 600 mg film-coated tablets
Gabapentina Sandoz 800 mg film-coated tablets
Read this prospect carefully before starting to take this medicine, as it contains important information for you.
Gabapentina Sandoz belongs to a group of medications used to treat epilepsy and peripheral neuropathic pain (chronic pain caused by nerve damage).
The active ingredient of Gabapentina Sandoz is gabapentin.
Gabapentin is used to treat:
Do not take Gabapentina Sandoz
Warnings and precautions
Consult your doctor or pharmacist before starting to take Gabapentina Sandoz.
There have been reports of abuse and dependence on gabapentin from post-marketing experience. Talk to your doctor if you have a history of abuse or dependence.
Dependence
Some people may develop dependence (need to keep taking the medicine) on Gabapentina Sandoz. They may experience withdrawal symptoms when they stop taking Gabapentina Sandoz (see section 3, "How to take Gabapentina Sandoz" and "If you interrupt treatment with Gabapentina Sandoz"). If you are concerned about developing dependence on Gabapentina Sandoz, it is essential to consult your doctor.
If you experience any of the following signs while taking gabapentin, it may be
indicative of dependence.
- You feel the need to take the medicine for longer than prescribed.
- You feel the need to take a higher dose than recommended.
- You are taking the medicine for reasons other than its prescription.
- You have tried several times to stop taking the medicine or control how you take it, without success.
- When you stop taking the medicine, you feel unwell and feel better when you take it again.
If you notice any of the above, talk to your doctor to decide on the best course of treatment for you, including when it is appropriate to stop treatment and how to do it safely.
A small number of people treated with antiepileptic drugs such as gabapentin have had thoughts of harming themselves or committing suicide. If you ever experience these thoughts, contact your doctor immediately.
Important information about potentially serious reactions
There have been reports of severe skin reactions associated with the use of gabapentin, including Stevens-Johnson syndrome, toxic epidermal necrolysis, and drug reaction with eosinophilia and systemic symptoms (DRESS). Stop taking gabapentin and seek medical attention immediately if you notice any of the symptoms related to these severe skin reactions described in section 4
Read the description of these symptoms in section 4 of this leaflet in the section“Contact your doctor immediately if you experience any of the following symptoms after taking this medicine, as they may be serious”.
Muscle weakness, sensitivity, or pain, and especially if you feel unwell or have a fever, could be due to an abnormal breakdown of muscle fibers that may lead to kidney problems and put your life at risk. You may also experience urine discoloration, and changes in blood test results (significant increase in creatine phosphokinase in blood). If you experience any of these signs or symptoms, please contact your doctor immediately.
Other medicines and Gabapentina Sandoz
Inform your doctor or pharmacist if you are taking, have taken recently, or may need to take any other medicine. Especially, inform your doctor (or pharmacist) if you are taking or have taken recently any medicine for seizures, sleep disorders, depression, anxiety, or any other neurological or psychiatric problem.
Medicines containing opioids such as morphine
If you are taking any medicine that contains opioids (such as morphine), inform your doctor or pharmacist, as opioids can increase the effect of gabapentin. Additionally, the combination of gabapentin with opioids may cause symptoms such as drowsiness and/or decreased breathing.
Antacids for indigestion
If you take gabapentin at the same time as antacids that contain aluminum and magnesium, the absorption of gabapentin in the stomach may be reduced. It is recommended that gabapentin be taken at least two hours after taking an antacid.
Gabapentin:
Taking Gabapentina Sandoz with food
Gabapentina Sandoz can be taken with or without food.
Pregnancy, breastfeeding, and fertility
If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor or pharmacist before using this medicine.
Pregnancy
You should not take gabapentin during pregnancy, unless your doctor has told you to. You should use an effective contraceptive method in women of childbearing age.
There are no specific studies on the use of gabapentin in pregnant women, but in the case of other medicines used to treat seizures, there have been reports of an increased risk of damage to the developing fetus, particularly when more than one medicine is used to treat seizures at the same time. If you take gabapentin during pregnancy, it may cause withdrawal symptoms in newborns. This risk may be higher when gabapentin is taken concomitantly with opioid analgesics (pain medications). Therefore, whenever possible, you should try to take only one medicine for seizures and only under the advice of your doctor.
Contact your doctor immediately if you become pregnant, think you may be pregnant, or plan to become pregnant while taking gabapentin. Do not stop taking this medicine abruptly, as this may cause an anticipation of seizures, which could have serious consequences for you and your baby.
Breastfeeding
Gabapentin, the active ingredient of Gabapentina Sandoz, passes into breast milk. It is not recommended to breastfeed while taking gabapentin, as its effect on the baby is unknown.
Fertility
There are no effects on fertility in animal studies.
Driving and operating machinery
Gabapentin may cause dizziness, drowsiness, and fatigue. Do not drive, operate heavy machinery, or engage in other potentially hazardous activities until you know if this medicine affects your ability to perform other activities.
Gabapentina Sandoz contains lecithin from soy and sodium
This medicine contains lecithin from soy. Do not use it in case of an allergy to peanuts or soy.
This medicine contains less than 1 mmol of sodium (23 mg) per coated tablet; it is essentially "sodium-free".
Follow exactly the administration instructions of this medication indicated by your doctor or pharmacist. In case of doubt, consult your doctor or pharmacist again. Do not take a higher dose of medication than prescribed.
Your doctor will determine the suitable dose for you.
Epilepsy, the recommended dose is:
Adults and adolescents:
Take the number of capsules indicated by your doctor. Normally, your doctor will gradually increase your dose. The initial dose will generally be 300 to 900 mg per day. From there, the dose can be increased as indicated by your doctor up to a maximum dose of 3,600 mg per day, divided into three equal doses, for example, one in the morning, one at noon, and one at night.
Children 6 years or older:
Your doctor will decide on the dose to be administered to your child based on the child's weight. Treatment will begin with a low initial dose that will be gradually increased over a period of approximately 3 days. The normal dose for controlling epilepsy is 25-35 mg per kg per day. The dose is usually administered by taking the capsules, divided into 3 equal doses per day, normally one in the morning, one at noon, and one at night.
Not all recommended doses are possible with this formulation. There are other gabapentin preparations available that may be more suitable.
It is not recommended to use gabapentin in children under 6 years of age.
Peripheral neuropathic pain, the recommended dose is:
Adults:
Take the number of capsules indicated by your doctor. Normally, your doctor will gradually increase your dose. The initial dose will generally be 300 to 900 mg per day. From there, the dose can be increased as indicated by your doctor up to a maximum dose of 3,600 mg per day, divided into three equal doses, for example, one in the morning, one at noon, and one at night.
If you have kidney problems or are receiving hemodialysis
Your doctor may prescribe another dosing regimen and/or a different dose if you have kidney problems or are receiving hemodialysis.
If you are an elderly patient (over 65 years of age), you should take the normal dose of gabapentin, except if you have kidney problems. Your doctor may prescribe another dosing regimen or different doses if you have kidney problems.
If you consider that the effect of gabapentin is too strong or too weak, inform your doctor or pharmacist as soon as possible.
Administration form
Gabapentin Sandoz is administered orally. Swallow the capsules whole with a sufficient amount of water.
Continue taking gabapentin until your doctor tells you to stop.
If you take more Gabapentina Sandoz than you should
Doses higher than recommended may cause an increase in adverse effects, including loss of consciousness, dizziness, double vision, slurred speech, numbness, and diarrhea.
In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicological Information Service, phone: 91 562 04 20, indicating the medication and the amount ingested.
Call your doctor or go to the nearest hospital emergency room if you take more gabapentin than your doctor prescribed. Bring with you any capsules you have not taken, along with the packaging and the leaflet so that the hospital can easily identify the medication you have taken.
If you forgot to take Gabapentina Sandoz
If you forgot to take a dose, take it as soon as you remember, unless it is time for the next dose. Do not take a double dose to compensate for the missed doses.
If you interrupt the treatment with Gabapentina Sandoz
Do not stop taking Gabapentina Sandoz suddenly. If you want to stop taking Gabapentina Sandoz, talk to your doctor first. Your doctor will indicate how to proceed. If you are going to stop treatment, this should be done gradually over a minimum of one week. You should know that you may experience certain adverse effects, called withdrawal syndrome, after interrupting a short or long-term treatment with gabapentin. These include seizures, anxiety, difficulty sleeping, feeling unwell (nausea), pain, sweating, tremors, headache, depression, abnormal sensation, dizziness, and general feeling of unwellness. These effects usually occur within the first 48 hours after stopping gabapentin treatment. If you experience this withdrawal syndrome, contact your doctor.
If you have any other doubts about the use of this medication, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everyone will experience them.
Stop taking Gabapentina Sandoz and seek medical attention immediately if you notice any of the following symptoms:
Contact your doctor immediately if you experience any of the following symptoms after taking this medicine, as they may be serious:
Contact your doctor immediately if you have any of the following symptoms:
These symptoms may be the first signs of a severe reaction. You should have a doctor examine you to decide if you should continue taking gabapentin.
If you are on hemodialysis, inform your doctor if you start feeling muscle pain and/or weakness.
Other side effects include:
Very common: (may affect more than 1 in 10 people)
Common: (may affect up to 1 in 10 people)
Additionally, in clinical trials in children, aggressive behavior and spasmodic movements were reported as frequent side effects.
Uncommon: (may affect up to 1 in 100 people)
Rare: (may affect up to 1 in 1,000 people)
Adverse reactions reported after the marketing of gabapentin:
Unknown frequency:(cannot be estimated from available data)
You should know that you may experience certain side effects, called withdrawal syndrome, after interrupting a short or long-term treatment with Gabapentina Sandoz (see "If you stop taking Gabapentina Sandoz").
Other possible side effects
Very rarely, soy lecithin may cause allergic reactions.
Reporting of adverse reactions
If you experience any type of side effect, consult your doctor or pharmacist, even if it is a possible side effect that does not appear in this leaflet. You can also report them directly through the Spanish System for the Vigilance of Medicinal Products for Human Use:https://www.notificaram.es.
By reporting adverse reactions, you can contribute to providing more information on the safety of this medicine.
Keep this medication out of the sight and reach of children.
Do not use this medication after the expiration date that appears on the packaging and the blister pack after CAD/EXP. The expiration date is the last day of the month indicated.
Do not store at a temperature above 25°C.
Medicines should not be disposed of through drains or in the trash. Dispose of the packaging and unused medications at the SIGRE collection point at the pharmacy. If in doubt, ask your pharmacist how to dispose of unused packaging and medications. By doing so, you will help protect the environment.
Composition of Gabapentina Sandoz
The active ingredient is gabapentin.
Gabapentina Sandoz 600 mg: Each film-coated tablet contains 600 mg of gabapentin.
Gabapentina Sandoz 800 mg: Each film-coated tablet contains 800 mg of gabapentin.
The other components are:
Core tablet: macrogol 4000, pregelatinized cornstarch, anhydrous colloidal silica, magnesium stearate.
Coating: polyvinyl alcohol, titanium dioxide (E 171), talc, soy lecithin, xanthan gum.
Appearance of the product and contents of the package
Film-coated tablet.
Gabapentina Sandoz 600 mg film-coated tablets:
are white, film-coated tablets in capsule shape with an inscription (600) on one side.
Gabapentina Sandoz 800 mg film-coated tablets:
are white, film-coated tablets in capsule shape.
The tablets are presented in PVC/aluminium blisters included in carton boxes.
Package sizes:
50, 60, 90, 100, 200, 200 (2x100) and sample packs with 20 film-coated tablets.
Note: The samples do not apply to Spain.
Only some package sizes may be marketed.
Marketing authorization holder and responsible manufacturer
Marketing authorization holder
Sandoz Farmacéutica, S.A.
Centro Empresarial Parque Norte
Edificio Roble
C/ Serrano Galvache, 56
28033 Madrid
Spain
Responsible manufacturer
Zambon S.p.A.
Via Della Chimica, 9
36100 Vicenza
Italy
or
Salutas Pharma GmbH
Otto-von Guericke Allee 1
39179 Barleben
Germany
This medicinal product is authorized in the Member States of the European Economic Area and in the United Kingdom (Northern Ireland) under the following names:
Bélgica:Gabapentin Sandoz 600 mg filmomhulde tabletten
Gabapentin Sandoz 800 mg filmomhulde tabletten
Finlandia:Gabapentin Sandoz 600 mg tabletti, kalvopäällysteinen
Gabapentin Sandoz 800 mg tabletti, kalvopäällysteinen
Francia:GABAPENTINE SANDOZ 600 mg, comprimé pelliculé
GABAPENTINE SANDOZ 800 mg, comprimé pelliculé
Holanda:Gabapentine Sandoz 600 mg filmomhulde tabletten
Gabapentine Sandoz 800 mg filmomhulde tabletten
Suecia:Gabapentin 1A-Farma 600 mg filmdragerade tabletter
Gabapentin 1A-Farma 800 mg filmdragerade tabletter
Reino Unido:GabapentinSandoz600 mg Tablets
Gabapentin Sandoz 800 mg Tablets
Last review date of this leaflet:February 2023.
The detailed information on this medicinal product is available on the website of the Spanish Agency for Medicines and Medical Devices (AEMPS)http://www.aemps.gob.es/
Есть вопросы по этому лекарству или вашим симптомам? Свяжитесь с лицензированным врачом для получения помощи и персонализированного ухода.